Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Idexx Laboratories, (IDXX) and more
MarketsFN Team

Nasdaq 100 52-Week Highs & Lows Radar: Electronic Arts, (EA), Idexx Laboratories, (IDXX) and more
Screening all 101 Nasdaq 100 constituents for stocks nearest to their 52-week high and their 52-week low. Data as of September 04, 2026. % Realized = 52-week total return.
Legend: RSI > 70 = overbought Β· RSI < 30 = oversold Β· Green % Realized = positive 52W return Β· Red = negative.
📈 Nearest to 52-Week High
Sectors represented: Healthcare (3), Communication Services (1), Technology (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week High Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-08-04 | β | β | β |
| NVDA | NVIDIA Corp | Technology | $233.90 | +36.26% | 2026-05-14 | 62.4 | +18.9% | Above MA20, MA50, MA200 |
| VRTX | Vertex Pharmaceuticals, Inc | Healthcare | $551.35 | +38.90% | 2026-09-03 | 62.7 | +18.3% | Above MA20, MA50, MA200 |
| AMGN | AMGEN Inc | Healthcare | $437.67 | +56.25% | 2026-09-03 | 62.3 | +22.1% | Above MA20, MA50, MA200 |
| BIIB | Biogen Inc | Healthcare | $221.01 | +57.93% | 2026-09-03 | 58.2 | +15.7% | Above MA20, MA50, MA200 |

EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: β | % above MA200: β | Trend: β
Electronic Arts, Inc (EA) is a leading interactive entertainment software company that develops and publishes games such as FIFA, Madden NFL, and The Sims. Investors should care about its performance in the gaming market and its ability to innovate and release successful titles.
The stock is near its 52-Week high, with a 0.0% discount, and has returned 0.4% over the 52-Week period. However, RSI and MA data are incomplete, making it difficult to assess momentum; the available data does not indicate a clear technical trend.

NVDA | NVIDIA Corp | Technology | Price Last: $233.90 | % Realized: +36.26% | RSI: 62.4 | % above MA200: +18.9% | Trend: Above MA20, MA50, MA200
NVIDIA Corp is a leader in GPU technology and AI computing, driving growth in gaming, professional visualization, datacenter, and automotive markets. Investors care due to its dominance in high-growth areas and potential for continued innovation.
NVIDIA Corp's RSI(14) is 62.4, indicating rising momentum. The stock is in a sustained uptrend with price > MA20 > MA50 > MA200. It's 0.8% below its 52-Week high, nearing a potential breakout, with a 36.3% 52-Week return.
Related headlines

VRTX | Vertex Pharmaceuticals, Inc | Healthcare | Price Last: $551.35 | % Realized: +38.90% | RSI: 62.7 | % above MA200: +18.3% | Trend: Above MA20, MA50, MA200
Vertex Pharmaceuticals, Inc is a biotechnology company that develops and commercializes therapies for cystic fibrosis and other serious diseases, with a focus on treating the underlying cause of the condition, making it an attractive investment for those seeking growth in the biotech sector.
Vertex Pharmaceuticals shows a sustained uptrend with a bullish MA alignment (price > MA20 > MA50 > MA200) and RSI(14) at 62.7, indicating momentum; it's 1.2% below its 52-Week high, suggesting a potential breakout.
Related headlines
- Vertex Completes $10 Billion Crinetics Acquisition, Adding Rare Endocrine Growth Platform
- Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team
- Vertex to Participate in Upcoming September Investor Conferences
- Vertex Stock Jumps 5.9% as Rival Cystic Fibrosis Drug Fails

AMGN | AMGEN Inc | Healthcare | Price Last: $437.67 | % Realized: +56.25% | RSI: 62.3 | % above MA200: +22.1% | Trend: Above MA20, MA50, MA200
AMGEN Inc is a biotechnology company that develops and markets human therapeutics, focusing on innovative treatments for serious illnesses such as cancer, cardiovascular disease, and bone disease, with a diverse portfolio of blockbuster drugs.
AMGN's technicals indicate sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 62.3, and is 1.5% below its 52-Week high, suggesting momentum near a potential breakout level, with 56.3% return over the 52-Week period.
Related headlines

BIIB | Biogen Inc | Healthcare | Price Last: $221.01 | % Realized: +57.93% | RSI: 58.2 | % above MA200: +15.7% | Trend: Above MA20, MA50, MA200
Biogen Inc is a biotechnology company that develops treatments for neurological and neurodegenerative diseases. Investors should care because its therapies for conditions like multiple sclerosis have significant market potential and the company's pipeline impacts its growth prospects.
Biogen's current technical situation indicates sustained uptrend with price > MA20 > MA50 > MA200, RSI(14) at 58.2, and is 1.6% below its 52-Week high, suggesting momentum near a potential breakout level after a 57.9% 52-Week return.
Related headlines
- Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
- Stoke Therapeutics and Biogen to present four-year zorevunersen data at epilepsy congress
- Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
📉 Nearest to 52-Week Low
Sectors represented: Healthcare (1), Consumer Cyclical (1), Communication Services (1), Consumer Defensive (1), Utilities (1)
| Ticker | Company | Sector | Price Last | % Realized | 52-Week Low Date | RSI | % above MA200 | Trend |
|---|---|---|---|---|---|---|---|---|
| IDXX | Idexx Laboratories, Inc | Healthcare | $525.69 | -17.92% | 2026-09-04 | 36.9 | -13.4% | Below MA20, MA50, MA200 |
| LULU | Lululemon Athletica inc | Consumer Cyclical | $99.56 | -51.69% | 2026-09-04 | 31.2 | -34.8% | Below MA20, MA50, MA200 |
| EA | Electronic Arts, Inc | Communication Services | $209.70 | +0.38% | 2026-07-17 | β | β | β |
| PEP | PepsiCo Inc | Consumer Defensive | $138.84 | -5.48% | 2026-07-23 | 45.4 | -6.7% | Below MA20, MA50, MA200 |
| EXC | Exelon Corp | Utilities | $43.99 | +1.50% | 2025-09-16 | 41.2 | -4.2% | Below MA20, MA50, MA200 |

IDXX | Idexx Laboratories, Inc | Healthcare | Price Last: $525.69 | % Realized: -17.92% | RSI: 36.9 | % above MA200: -13.4% | Trend: Below MA20, MA50, MA200
Idexx Laboratories, Inc is a veterinary diagnostics company providing testing solutions and companion animal care products. Investors should care about its innovation in pet healthcare and potential for growth in the $7 billion global veterinary diagnostics market.
IDXX is in a sustained downtrend with price < MA20 < MA50 < MA200, RSI(14) at 36.9, and is 0.0% above its 52-Week low, indicating a warning sign as it tests major support with a 52-Week return of -17.9%.
Related headlines
- IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
- IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
- IDEXX Laboratories, Inc. Q2 2026 Earnings Call Summary
- IDEXX Laboratories Inc (IDXX) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...

LULU | Lululemon Athletica inc | Consumer Cyclical | Price Last: $99.56 | % Realized: -51.69% | RSI: 31.2 | % above MA200: -34.8% | Trend: Below MA20, MA50, MA200
Lululemon Athletica inc is a premium athletic apparel retailer. Investors should care about its ability to maintain market share and pricing power in a competitive yoga and running wear market, as well as its capacity to expand into new markets and demographics.
Lululemon's current technical situation is bearish, with an RSI(14) of 31.2 indicating oversold conditions, and the stock price below MA20, MA50, and MA200, showing a lack of momentum. It's testing major support at its 52-Week low.
Related headlines
- Lululemon Stock Falls 18% as Tariff Refunds Mask Sales Decline
- Michael Burry Sends Shocking Message on Tumbling Lululemon Stock
- Stock Market Today: Dow Falls Ahead Of Jobs Report; Lululemon Plunges 21% As Tesla Sinks (Live Coverage)
- Lululemon stock plunged after slashing its annual forecast for the second time

EA | Electronic Arts, Inc | Communication Services | Price Last: $209.70 | % Realized: +0.38% | RSI: β | % above MA200: β | Trend: β
Electronic Arts, Inc (EA) is a leading interactive entertainment software company that develops and publishes games such as FIFA, Madden NFL, and The Sims. Investors should care about its performance in the gaming market and its ability to innovate and release successful titles.
The stock is near its 52-Week high, with a 0.0% discount, and has returned 0.4% over the 52-Week period. However, RSI and MA data are incomplete, making it difficult to assess momentum; the available data does not indicate a clear technical trend.

PEP | PepsiCo Inc | Consumer Defensive | Price Last: $138.84 | % Realized: -5.48% | RSI: 45.4 | % above MA200: -6.7% | Trend: Below MA20, MA50, MA200
PepsiCo Inc is a diversified food and beverage company with brands like Pepsi, Lay's, and Gatorade, generating revenue through beverage sales, snack foods, and other categories, making it a significant player in the consumer staples sector.
PepsiCo's technicals indicate a warning sign with an RSI(14) of 45.4, below all MA levels (MA20/MA50/MA200), and only 2.9% above its 52-Week low, suggesting testing of major support after a -5.5% return over the 52-Week period.
Related headlines

EXC | Exelon Corp | Utilities | Price Last: $43.99 | % Realized: +1.50% | RSI: 41.2 | % above MA200: -4.2% | Trend: Below MA20, MA50, MA200
Exelon Corp (EXC) is a utility company that generates and distributes electricity, operating nuclear, natural gas, and renewable energy facilities. Investors care about its stable cash flows and dividend yield, given its role in supplying electricity to a large customer base.
Exelon Corp's current technical situation is bearish, with an RSI(14) of 41.2 indicating weakening momentum. The MA alignment (price < MA20 < MA50 < MA200) confirms a sustained downtrend, and the stock is near its 52-Week low, 2.9% above it, testing major support.
Related headlines
- Exelon Announces Key Leadership Position Changes
- Exelon Secures More Than $1 Billion in Customer Protections Through Pioneering Transmission Security Agreements
- Exelon high probability data center load falls 40%
- Exelon Corp (EXC) (Q2 2026) Earnings Call Highlights: Navigating Regulatory Hurdles and Data ...
Market Commentary
The Nasdaq 100 stocks near 52-week extremes signal a significant trend in the technology sector. Stocks like NVDA and AMGN are near 52-week highs, indicating strong investor confidence, while IDXX and LULU are at 52-week lows, suggesting potential concerns.
The technology sector is driven by various macro themes, including innovation and growth prospects. Companies like NVDA, a leader in AI and graphics processing, are near 52-week highs, reflecting the sector's growth potential. Conversely, stocks like IDXX and LULU, near 52-week lows, may be influenced by factors such as market sentiment and consumer demand.
Key levels to watch include the 52-week extremes for these stocks. A breakout above the 52-week high for NVDA (-0.8% away) or a breakdown below the 52-week low for IDXX (at the low) could be significant. Potential catalysts include earnings reports and industry trends. For instance, EA is near both its 52-week high and low, indicating a tight trading range and potential for a breakout in either direction.
Methodology: All 101 Nasdaq 100 constituents screened. 52-week high = highest daily close over the past 252 trading days (approx. 1 year). 52-week low = lowest daily close over the same period. Distance = (current price / extreme β 1) Γ 100. Technical indicators computed on up to 1 year of daily OHLCV data.
Disclaimer: For informational purposes only. Not investment advice. Past performance is not indicative of future results.

